You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
Another owner of the lab also received kickbacks from third parties for referring individuals to those parties totaling $441,646.
The owner of Specialty Drug Testing, a Monroe, Louisiana-based laboratory, appeared in United States District Court accused of violating the Anti-Kickback Statute.
The federal government alleged Phamatech paid a clinic to refer it drug testing business, violating the federal Anti-Kickback Statute and the False Claims Act.
From 2009 to 2012, the laboratory allegedly billed Medicare for testing on hospital inpatients that should have been billed to the hospitals.
Along with the federal settlement, the company will also pay an additional $13.2 million to settle civil claims by different state attorneys general.
Last month the agency said it had begun examining Medicare claims data to look for potential fraud in ordering of SARS-CoV-2 testing and related tests.
The US DOJ alleged that the company conspired to "artificially delay" ordering its MammaPrint test in order to circumvent Medicare's 14-day rule.
William Hughes, the owner and operator of the Greensburg, Pennsylvania-based lab, made cash payments for referrals between October 2011 and August 2013.
The lab firm was accused of billing government payors for unnecessary testing as well as paying illegal compensation to phlebotomy vendors.
The lawsuit also alleges Anthem failed to delete inaccurate diagnosis codes, leading to inflated risk-adjustment payments from Medicare.